754
M. C. Cruz et al.
LETTER
2229. (e) Yue, D.; Larock, R. C. Org. Lett. 2004, 6, 1037.
(f) Shen, M.; Li, G.; Lu, B. Z.; Hossain, A.; Roschangar, F.;
Farina, V.; Senanayake, C. H. Org. Lett. 2004, 6, 4129.
(g) Nazaré, M.; Schneider, C.; Lindenschmidt, A.; Will, D.
W. Angew. Chem. Int. Ed. 2004, 43, 4526. (h) Siu, J.;
Baxendale, I. R.; Ley, S. V. Org. Biomol. Chem. 2004, 2,
160. (i) Amjad, M.; Knight, D. W. Tetrahedron Lett. 2004,
45, 539. (j) Ackermann, L.; Born, R. Tetrahedron Lett.
2004, 45, 9541. (k) Arcadi, A.; Bianchi, G.; Marinelli, F.
Synthesis 2004, 610. (l) Hiroya, K.; Itoh, S.; Sakamoto, T. J.
Org. Chem. 2004, 69, 1126. (m) Cacchi, S.; Fabrizi, G.
Chem. Rev. 2005, 105, 2873. (n) Barluenga, J.; Vázquez-
Villa, H.; Ballesteros, A.; González, J. M. Adv. Synth. Catal.
2005, 347, 526. (o) Söderberg, B. C. G.; Hubbard, J. W.;
Rector, S. R.; O’Neil, S. N. Tetrahedron 2005, 61, 3637.
(p) Ackermann, L. Org. Lett. 2005, 7, 439. (q) Arcadi, A.;
Cacchi, S.; Fabrizi, G.; Marinelli, F.; Parisi, L. M. J. Org.
Chem. 2005, 70, 6213.
(CO2CH3), 98.6 (NC=), 113.4 (C-2), 117.9 (C-4), 129.0
(C-3), 146.3 (HC=), 149.1 (C-1), 169.6 (CO2CH3).
Compound 6c: 1H NMR (300 MHz, CDCl3): d = 2.22 (s, 3
H, CH3Ar), 3.01 [s, 6 H, N(CH3)2], 3.60 (s, 3 H, CO2CH3),
4.52 (br s, 1 H, NH), 6.51–6.57 (m, 2 H, H-2), 6.93–7.00 (m,
2 H, H-3), 7.36 (s, 1 H, HC=). 13C NMR (75.4 MHz, CDCl3):
d = 20.3 (CH3Ar), 41.6 [N(CH3)2], 51.1 (CO2CH3), 99.1
(NC=), 113.4 (C-2), 127.1 (C-4), 129.5 (C-3), 146.1 (HC=),
146.8 (C-1), 169.6 (CO2CH3).
Compound 6h: 1H NMR (300 MHz, CDCl3): d = 1.20 (t,
J = 7.2 Hz, 3 H, CH3CH2O), 3.03 [s, 6 H, N(CH3)2], 3.73 (s,
6 H, OMe), 4.10 (q, J = 7.2 Hz, 2 H, CH3CH2O), 4.70 (br s,
1 H, NH), 5.84 (d, J = 2.1 Hz, 2 H, H-2, H-6), 5.89 (t, J = 2.1
Hz, 1 H, H-4), 7.36 (s, 1 H, HC=). 13C NMR (75.4 MHz,
CDCl3): d = 14.6 (CH3CH2O), 41.8 [N(CH3)2], 55.05 (OMe),
55.08 (OMe), 59.7 (CO2CH2CH3), 90.3 (C-4), 92.4 (C-2, C-
6), 98.8 (NC=), 146.0 (HC=), 151.5 (C-1), 161.5 (C-3, C-5),
169.0 (CO2Et).
(10) Typical Procedure for Preparation of 7b.
(12) Typical Procedure for Preparation of 5b.
Under an N2 atmosphere, a mixture of 8b (1.0 g, 9.33 mmol)
and anhyd K2CO3 (1.93 g, 14.0 mmol) in dry acetone (10
mL) was heated to 60 °C for 1 h. Methyl bromoacetate (9,
1.57 g, 10.26 mmol) was added dropwise and the mixture
was stirred at 60 °C for 12 h. The mixture was filtered and
the solvent was removed under vacuum. The residue was
purified by column chromatography over silica gel (20 g/g of
sample, hexane–EtOAc, 95:5), to give 1.44 g (86%) of 7b as
a brownish solid.
Rf = 0.45 (hexane–EtOAc, 8:2); mp 44–45 °C (hexane–
EtOAc, 8:2) [lit.16 40 °C]. IR (KBr): 3393, 1741, 1608, 1513,
1439, 1213, 1180, 772 cm–1. 1H NMR (300 MHz, CDCl3):
d = 2.33 (s, 3 H, CH3Ar), 3.81 (s, 3 H, CO2Me), 3.93 (s, 2 H,
CH2N), 4.24 (br s, 1 H, NH), 6.43–6.49 (m, 2 H, H-2, H-6),
6.63 (br d, J = 7.5 Hz, 1 H, H-4), 7.13 (t, J = 7.5 Hz, 1 H, H-
5). 13C NMR (75.4 MHz, CDCl3): d = 21.4 (CH3Ar), 45.4
(CH2N), 51.9 (CO2CH3), 109.8 (C-6), 113.6 (C-2), 118.9 (C-
4), 129.0 (C-5), 138.8 (C-3), 146.8 (C-1), 171.5 (CO2Me).
MS (70 eV): m/z (%) = 179 (65) [M+], 136 (7), 122 (34), 121
(100), 93 (3), 63 (5).
Anhyd AlCl3 (0.057 g, 0.43 mmol) was added to a solution
of 6b (0.10 g, 0.43 mmol) in dry CH2Cl2 (100 mL) at r.t. The
mixture was stirred at r.t. for 24 h and filtered. The filtrate
was washed with H2O (3 × 25 mL), the organic layer was
dried (Na2SO4), and the solvent was removed under vacuum.
The residue was purified by column chromatography over
silica gel (10 g, hexane–EtOAc, 95:5), to give 0.061 g (76%)
of 5b as a white solid.
Rf = 0.33 (hexane–EtOAc, 8:2); mp 97–98 °C (hexane–
EtOAc, 7:3) [lit.17 128–129 °C]. IR (KBr): 3324, 1697, 1527,
1441, 1333, 1262, 1211, 764 cm–1. 1H NMR (300 MHz,
CDCl3): d = 2.47 (s, 3 H, CH3Ar), 3.94 (s, 3 H, CO2Me), 6.99
(dd, J = 8.1, 0.9 Hz, 1 H, H-5), 7.18 (dd, J = 2.1, 0.9 Hz, 1
H, H-3), 7.20 (br s, 1 H, H-7), 7.56 (d, J = 8.1 Hz, 1 H, H-4),
8.85 (br s, 1 H, NH). 13C NMR (75.4 MHz, CDCl3): d = 22.0
(CH3Ar), 51.9 (CO2CH3), 108.8 (C-3), 111.5 (C-7), 122.2
(C-4), 123.0 (C-5), 125.3 (ArC), 126.5 (ArC), 135.7 (ArC),
157.3 (C-7a), 162.5 (CO2CH3). MS (70 eV):
m/z (%) = 189 (24) [M+], 175 (17), 157 (87), 129 (91), 103
(80), 102 (100), 77 (69), 51 (69).
(11) Typical Procedure for Preparation of 6b.
NMR spectral data of representative examples.
A mixture of 7b (0.20 g, 1.12 mmol) and DMFDMA (0.20
g, 1.68 mmol) was heated to 90 °C for 5 h, under an N2
atmosphere. The crude mixture was evaporated under
vacuum and the residue was purified by column
Compound 5a: 1H NMR (300 MHz, CDCl3): d = 3.95 (s, 3
H, CO2CH3), 7.16 (ddd, J = 8.1, 6.8, 1.0 Hz, 2 H, H-5), 7.23
(dd, J = 2.3, 1.0 Hz, 1 H, H-3), 7.33 (ddd, J = 8.4, 6.8, 1.0
Hz, 1 H, H-6), 7.58 (ddd, J = 8.4, 1.0, 0.9 Hz, 1 H, H-7), 7.70
chromatography over silica gel (20 g/g of sample, hexane–
EtOAc, 8:2), to give 0.21 g (79%) of 6b as an orange solid.
Rf = 0.25 (hexane–EtOAc, 8:2); mp 65–72 °C (decomp.,
hexane–EtOAc, 8:2). IR (KBr): 3318, 3025, 1735, 1645,
1607, 1488, 1435, 1227, 777 cm–1. 1H NMR (300 MHz,
CDCl3): d = 2.26 (s, 3 H, CH3Ar), 3.02 [s, 6 H, N(CH3)2],
3.61 (s, 3 H, CO2CH3), 4.62 (br s, 1 H, NH), 6.40–6.47 (m,
2 H, ArH), 6.54 (br d, J = 7.8 Hz, 1 H, H-4), 7.04 (dd,
J = 7.8, 7.2 Hz, 1 H, H-5), 7.39 (s, 1 H, HC=). 13C NMR
(75.4 MHz, CDCl3): d = 21.5 (CH3Ar), 41.6 [N(CH3)2], 51.1
(CO2CH3), 98.6 (NC=), 110.4 (C-6), 114.1 (C-2), 118.9 (C-
4), 128.8 (C-5), 138.7 (C-3), 146.3 (HC=), 149.1 (C-1),
169.6 (CO2CH3). MS (70 eV): m/z (%) = 234 (4) [M+], 203
(3), 132 (6), 118 (14), 91 (36), 83 (18), 65 (16), 57 (66), 42
(100). Anal. Calcd for C13H18N2O2: C, 66.64; H, 7.74; N,
11.96. Found: C, 66.47; H, 7.64; N, 11.74.
(dd, J = 8.1, 0.9 Hz, 1 H, H-4), 8.98 (br s, 1 H, NH). 13
C
NMR (75.4 MHz, CDCl3): d = 52.0 (CO2CH3), 108.8 (C-3),
111.9 (C-7), 120.8 (C-5), 122.6 (C-4), 125.4 (C-6), 127.1 (C-
2), 127.4 (C-3a), 136.8 (C-7a), 162.4 (CO2CH3).
Compound 5c: 1H NMR (300 MHz, CDCl3): d = 2.43 (s, 3
H, CH3Ar), 3.94 (s, 3 H, CO2CH3), 7.14 (br s, 1 H, H-3), 7.15
(dd, J = 8.4, 1.5 Hz, 1 H, H-6), 7.31 (br d, J = 8.4 Hz, 1 H,
H-7), 7.45 (br s, 1 H, H-4), 9.11 (br s, 1 H, NH). 13C NMR
(75.4 MHz, CDCl3): d = 21.4 (CH3Ar), 51.9 (CO2CH3),
108.2 (C-3), 111.6 (C-7), 121.8 (C-4), 127.0 (C-2), 127.4
(C-6), 127.7 (C-5), 130.1 (C-3a), 135.3 (C-7a), 162.6
(CO2CH3).
Compound 5h: 1H NMR (300 MHz, CDCl3): d = 1.39 (t,
J = 7.0 Hz, 3 H, CH3CH2O), 3.83 (s, 3 H, OMe), 3.90 (s, 3
H, OMe), 4.38 (q, J = 7.0 Hz, 2 H, CH3CH2O), 6.18 (d,
J = 1.5 Hz, 2 H, H-2, H-5), 6.43 (dd, J = 1.5, 0.9 Hz, 1 H, H-
7), 7.27 (dd, J = 2.3, 0.9 Hz, 1 H, H-3), 9.10 (br s, 1 H, NH).
13C NMR (75.4 MHz, CDCl3): d = 14.4 (CH3CH2O), 55.3
(OMe), 55.5 (OMe), 60.7 (CO2CH2CH3), 86.1 (C-7), 92.6
(C-5), 106.7 (C-3), 113.7 (C-3a), 124.8 (C-2), 138.6 (C-7a),
155.0 (C-4), 160.1 (C-6), 162.1 (CO2Et).
NMR spectral data of representative examples.
Compound 6a: 1H NMR (300 MHz, CDCl3): d = 3.01 [s, 6
H, N(CH3)2], 3.62 (s, 3 H, CO2CH3), 4.66 (br s, 1 H, NH),
6.62 (br d, J = 7.5 Hz, 2 H, H-2), 6.72 (t, J = 7.5 Hz, 1 H, H-
4), 7.15 (br t, J = 7.5 Hz, 1 H, H-3), 7.40 (s, 1 H, HC=).
13C NMR (75.4 MHz, CDCl3): d = 41.6 [N(CH3)2], 51.1
Synlett 2006, No. 5, 749–755 © Thieme Stuttgart · New York